查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球虚拟临床试验市场
市场调查报告书
商品编码
1380440

2023-2030 年全球虚拟临床试验市场

Global Virtual Clinical Trials Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

预计全球虚拟临床试验市场在预测期内将以 8.5% 的CAGR成长。研发活动的增加、医疗保健数位化的提高以及远距医疗的采用是推动全球市场成长的关键因素。临床研究组织、製药和生物技术公司之间的联盟以及有凝聚力的政府措施进一步促进了市场的发展。

根据 2020 年 4 月发布的连续临床报告，约 30.0% 的接受调查的临床试验地点预计将对招募新试验研究患者以及保留已入组患者遵守其研究时间表产生巨大影响。此外，81%的欧洲临床试验研究中心和56.0%的美国临床试验研究中心表示患者不太可能继续参与研究。虚拟方法让人们在家中参与试验，确保即使在现场访问无法进行的情况下研究也可以继续，因此，代表了一种从临床研究参与者收集安全性和有效性资料的新方法。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • ICON PLC
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • IQVIA Holdings Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Laboratory Corporation of America Holdings (Covance Inc.)
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Oracle Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Parexel International Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按研究设计分類的全球虚拟临床试验市场
    • 介入治疗
    • 观察性
    • 扩大访问范围
  • 按适应症分類的全球虚拟临床试验市场
    • 心血管疾病
    • 肿瘤学
    • 其他（眼科、传染病等）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Biorasi
  • Clara Health
  • Clariness
  • Clinical Ink Inc.
  • CRF Health
  • Dassault Systemes SE (Medidata Solutions Inc.)
  • Halo Health System Inc.
  • ICON PLC
  • LEO Innovation Lab
  • Medable Inc.
  • Medpace Holdings Inc.
  • PRA Health Sciences
  • Signant Health
  • TrialBee Inc.
  • Worldwide Clinical Trials
Product Code: OMR2027842

Title: Global Virtual Clinical Trials Market Size, Share & Trends Analysis Report by Study Design (Observational, Interventional, and Expanded Access), and by Indication (Cardiovascular Diseases (CVDs), Oncology, and Others)Forecast Period (2023-2030).

The global virtual clinical trials market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period. The rise in R&D activities, increasing healthcare digitization, as well as the adoption of telehealth are the key factors driving the growth of the global market. The alliances between clinical research organizations, pharmaceutical, and biotechnology companies as well as cohesive government initiatives are further contributing to the market development.

As per the continuum clinical report published in April 2020, approximately 30.0% of the surveyed clinical trial places are projected to have a huge impact on recruiting patients for new trial studies as well as retaining already-enrolled patients compliant with their study schedules. Also, 81% of the European clinical trial study sites and 56.0% of the US sites indicated that the patients are less likely to continue participating in studies. A virtual method lets people take part in the trial from their homes ensuring research can continue even when site visits cannot, hence, representing a novel approach of collecting safety and efficacy data from participants of clinical studies.

Segmental Outlook

The global virtual clinical trials market is segmented based on study design and indication. Based on study design, the market is segmented into observational, interventional, and expanded access. Based on indication, the market is segmented into cardiovascular disease, oncology, and other indication types (ophthalmology, infectious disease, and other).

Oncology Held Considerable Share in Global Virtual clinical trials Market

The oncology segment held considerable share in the global market based on indication type. The rising cancer prevalence, increasing government initiatives for cancer awareness and increasing R&D activities on the development of cancer drugs has increased the number of oncological trials. according to estimates from the International Agency for Research on Cancer (IARC) updates from July 2021, by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases and 16.3 million deaths worldwide.

Virtual clinical trials minimize the cancer patient's risk and decrease time spent on face-to-face trial visits. To keep patients safe, oncology clinical trial investigators and sponsors have quickly incorporated virtual and remote trials. Such developments are further contributing to the growth of this market segment. According to the National Clinical Trials, in April 2020, around 8,306 clinical trials on oncology across the various phases of development were conducted.

Regional Outlook

The global virtual clinical trials market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among all the regions, the Asia-Pacific region is anticipated to exhibit highest CAGR during the forecast period. The regional growth is attributed to the increasing availability of a large patient pool enabling easy recruitment of candidates along with enhanced penetration of digital technologies across the region. For instance, in October 2022, Oracle and ObvioHealth entered into a strategic collaboration to integrate diverse data sets into virtual/decentralized clinical trials in the Asia-Pacific region. This initiative is anticipated to allow the quick collection, integration and analysis of multi-source data collected from devices, patients, and sites. Such activities of key players are further contributing to the regional market growth.

North America Held Considerable Share in the Global Virtual Clinical Trials Market

The increasing number of pharmaceutical R&D, increasing adoption of new technologies in clinical research as well as cohesive government policies are some of the prominent factors driving the regional market growth. For instance, in April 2023, Bobbie, the organic infant formula company announced its first virtual clinical trial, enabling the science-backed brand to double down on research, innovation and unique products and recipes for American parents. The first patient was enrolled for a study designed to evaluate the growth, tolerance, and safety of a new infant formula.

Parexel performed more than 100 decentralized trials including hybrid and virtual approaches. Covance also has around 1,900 LabCorp Patient Service Centers across the US that brings the trial to patients. Such development by key players across the region is further contributing to the growth of the regional market growth.

Market Players Outlook

The major companies serving the global virtual clinical trials market include: ICON PLC, Laboratory Corporation of America Holdings (Covance Inc.), Oracle Corp., Parexel International Corp., IQVIA Holdings Inc. among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2022, Signant Health introduced telemedicine platform innovations to optimize virtual and remote clinical trial operations.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global virtual clinical trials market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. ICON PLC
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. IQVIA Holdings Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Laboratory Corporation of America Holdings (Covance Inc.)
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Oracle Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Parexel International Corp.
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Virtual Clinical Trials Market by Study Design
    • 4.1.1. Interventional
    • 4.1.2. Observational
    • 4.1.3. Expanded Access
  • 4.2. Global Virtual Clinical Trials Market by Indication
    • 4.2.1. Cardiovascular Diseases
    • 4.2.2. Oncology
    • 4.2.3. Other (Ophthalmology, Infectious Disease, and other)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Biorasi
  • 6.2. Clara Health
  • 6.3. Clariness
  • 6.4. Clinical Ink Inc.
  • 6.5. CRF Health
  • 6.6. Dassault Systemes SE (Medidata Solutions Inc.)
  • 6.7. Halo Health System Inc.
  • 6.8. ICON PLC
  • 6.9. LEO Innovation Lab
  • 6.10. Medable Inc.
  • 6.11. Medpace Holdings Inc.
  • 6.12. PRA Health Sciences
  • 6.13. Signant Health
  • 6.14. TrialBee Inc.
  • 6.15. Worldwide Clinical Trials

LIST OF TABLES

  • 1. GLOBAL VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2022-2030 ($ MILLION)
  • 2. GLOBAL INTERVENTIONAL VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL OBSERVATIONAL VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL EXPANDED ACCESS VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL VIRTUAL CLINICAL TRIALS FOR CARDIOVASCULAR DISEASES (CVDS) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL VIRTUAL CLINICAL TRIALS FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL VIRTUAL CLINICAL TRIALS FOR OTHER INDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 13. EUROPEAN VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. EUROPEAN VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2022-2030 ($ MILLION)
  • 15. EUROPEAN VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY STUDY DESIGN, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD VIRTUAL CLINICAL TRIALS MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE BY STUDY DESIGN, 2022 VS 2030 (%)
  • 2. GLOBAL INTERVENTIONAL VIRTUAL CLINICAL TRIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL OBSERVATIONAL VIRTUAL CLINICAL TRIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL EXPANDED ACCESS VIRTUAL CLINICAL TRIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE BY INDICATION, 2022 VS 2030 (%)
  • 6. GLOBAL VIRTUAL CLINICAL TRIALS FOR CARDIOVASCULAR DISEASES (CVDS) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL VIRTUAL CLINICAL TRIALS FOR ONCOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL VIRTUAL CLINICAL TRIALS FOR OTHER INDICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD VIRTUAL CLINICAL TRIALS MARKET SIZE, 2022-2030 ($ MILLION)